YM BIOSCIENCES REPORTS THIRD QUARTER 2009 OPERATIONAL AND FINANCI... ( 2009 costs were $1.6 million similar to...)

YM BIOSCIENCES REPORTS THIRD QUARTER 2009 OPERATIONAL AND FINANCIAL RESULTS

Date:5/14/2009

, 2009 costs were $1.6 million, similar to the same period in the prior year.

Net loss for the third quarter of fiscal 2009 was $3.5 million ($0.06 per share) compared to $3.8 million ($0.07 per share) for the same period last year. Net loss for the first nine months of fiscal 2009 was $9.8 million ($0.18 per share) compared to $11.9 million ($0.21 per share) for the same period last year.

As at March 31, 2009 the Company had cash and cash equivalents and short-term deposits totaling $46.6 million and payables and accrued liabilities totaling $1.9 million compared to $58.1 million and $2.0 million respectively at June 30, 2008.

As at March 31, 2009 the Company had 58,216,309 common shares outstanding, of which 2,380,953 common shares are held in escrow to be released contingent upon the completion of certain milestones.

About YM BioSciences

YM BioSciences Inc. is a life sciences product development company that identifies and advances a portfolio of promising cancer-related products at various stages of development. The Company is currently developing two late-stage products: nimotuzumab, an EGFR-targeting Affinity-Optimized Antibody(TM), and AeroLEF(R), a proprietary, inhaled-delivery composition of free and liposome-encapsulated fentanyl. YM has proven regulatory and clinical trial expertise and a diversified business model designed to reduce risk while advancing clinical products toward international approval, marketing and commercialization.

Nimotuzumab is a humanized monoclonal antibody in development worldwide, targeting multiple tumor types primarily in combination with radiation and chemoradiation. It is significantly differentiated from all other currently marketed EGFR-targeting agents due to its remarkably benign side-effect profile. Nimotuzumab's anti-tumor activity has led to its approval for marketing in more than 12 countries. In more than 3,500 patients reported as having been treated
'/>"/>

SOURCE YM BioSciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11
Related biology technology :

1. Frost & Sullivan Awards Precision Biosciences for Technology Innovation and Molecular Design Process in the Genomics Market
2. Neurocrine Biosciences to Present at the Deutsche Bank 34th Annual Health Care Conference
3. MichBio Leader Cites New Senate Biosciences Task Force and House Subcommittee as Evidence of States Growing Awareness of Industrys Economic Importance
4. Neurocrine Biosciences Reports First Quarter 2009 Results
5. Sangamo BioSciences Receives $100,000 Grand Challenges Explorations Grant for Innovative Global Health Research
6. Sangamo BioSciences Announces Publication in Nature of the Use of Zinc Finger Nucleases to Accelerate Precision Trait Stacking in Commercial Crop Species
7. ImQuest BioSciences and Arisyn Therapeutics Announce Strategic Partnership to Develop Infectious Disease and Cancer Drugs
8. LaVoie Group Selected by Vaccine Developer, Profectus BioSciences, as Agency of Record
9. Former GE Healthcare Director, Per Foss Appointed CEO for HUNT Biosciences
10. Sangamo BioSciences Announces First Quarter 2009 Conference Call and Webcast
11. Cell Biosciences Launches Next-Generation Protein Characterization System

Post Your Comments:

(Date:6/18/2013)... Clara, CA (PRWEB) June 18, 2013 ... to standard size SEMs but have limited performance and ... lower resolution. Full size SEMs would normally provide better ... more knowledge to operate and have a higher cost ... address the gap between these two types of ...

(Date:6/18/2013)... 2013) A million electric cars could be on roads ... the help of research by the United States Department of ... , Professor Zhongwei Chen is part of a team led ... materials to replace the expensive platinum catalysts in fuel cells. ... fuel cells in vehicles is the cost of the units. ...

(Date:6/18/2013)... Cord Blood Corporation (NYSE: CO ) ("CCBC" ... collection, laboratory testing, hematopoietic stem cell processing, and stem ... results for the fourth quarter and full year of ... Fourth Quarter of Fiscal 2013 Highlights , ... by 33.3% to RMB133.0 million ($21.4 million) from RMB99.8 ...

(Date:6/18/2013)... June 18, 2013 In support of ... the Consulate General of Switzerland in New York is ... Switzerland’s MS Tûranor PlanetSolar , to Manhattan. PlanetSolar ... DeepWater Expedition 2013 tour with scientists on board from ... Gérard d’Aboville, runs exclusively on energy from the sun ...

[0] Nanounity Introduces the Pemtron Range of Compact Scanning Electron Microscopes [0] US and Canadian researchers drive towards cheaper fuel cells for electric cars [0] China Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2013 [0] Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City

... a novel class of intracellular protein biologics, today ... of naturally occurring human supercharged proteins called Intraphilins. ... human proteins enable biologic drugs to penetrate and ... of proteins is the foundation of Permeon Biologics, ...

... form protein clumps in the body, then alarm bells ... associated with Alzheimer,s disease and type 2 diabetes, formerly ... proteins form clumps, then they might be able to ... Keller and his colleagues at the Helmholtz-Zentrum Dresden-Rossendorf and ...

... 2011 Gen-Probe Incorporated (NASDAQ: GPRO ) today ... total revenues of $135.9 million and non-GAAP earnings per share ... of APTIMA women,s health products in the second quarter of ... decline compared to strong sales a year ago," said Carl ...

Permeon reveals discovery of Intraphilins as new approach to intracellular biologic drugs In the pursuit of dangerous clumps Gen-Probe Reports Financial Results for the Second Quarter of 2011

(Date:6/17/2013)... research published in Biochemical and Biophysical Research Communications ... can detect new, previously unknown viruses. The technique offers ... doctors have not identified a particular virus as the ... the new approach, scientists use blood serum as a ... advantage of the complete deciphering of the human genome, ...

(Date:6/17/2013)... MANHATTAN, KAN. -- A Kansas State University research associate ... on mosquitoes and ways to prevent the spread of ... received the National Institutes of Health,s National Research Service ... years. He is the seventh Kansas State University researcher ... on campus to currently hold such an award. , ...

(Date:6/17/2013)... . A new ... disease can be reversed with treatment. The study by researchers ... at McGill University and at Universit de Montral found that ... of mice with advanced Alzheimer,s disease (AD) recovers memory and ... Neuroinflammation in May, also suggest an underlying mechanism of ...

Breaking Biology News(10 mins):Saint Louis University researchers discover a way to detect new viruses 2 Saint Louis University researchers discover a way to detect new viruses 3 NIH fellowship helps researcher fight malaria, understand mosquito immunity 2 Blocking overactive receptor in Alzheimer's recovers memory loss and more 2

[0] Saint Louis University researchers discover a way to detect new viruses [0] NIH fellowship helps researcher fight malaria, understand mosquito immunity [0] Blocking overactive receptor in Alzheimer's recovers memory loss and more

... plants--is the most abundant biological material on Earth. ... plant-based biofuels research. Despite overwhelming interest, scientists know ... cellulose fibers. , However, recent work from the ... University describes the first real-time observations of cellulose ...

... of biomedical engineering at New Jersey Institute of Technology (NJIT) ... has received two grants that will help her bring the ... , Arinzeh received a $700,000 grant from ... agency that funds spinal cord research. She will use the ...

... When medics are treating trauma patients, every second counts. ... it difficult to locate veins and administer lifesaving drugs ... Institute of Technology researchers is developing an inexpensive, handheld ... quickly. , "Depth and angle are the critical ...

Cached Biology News:Formation of cellulose fibers tracked for the first time 2 NJIT engineer poised to take stem cell research a step forward 2 NJIT engineer poised to take stem cell research a step forward 3 Researchers develop portable 'vein finder' for faster, more accurate injections 2 Researchers develop portable 'vein finder' for faster, more accurate injections 3

Formation of cellulose fibers tracked for the first time NJIT engineer poised to take stem cell research a step forward Researchers develop portable 'vein finder' for faster, more accurate injections

... Maximize the value of your microarray ... offer the support you need from ... the most up to date methods. ... the Gene Expression Profiling Service or ...

... number is a new product number, ... number. If showing no availability yet, ... number (Z71,517-4) or contact customer service ... (expanded surface, easy grip) ...

... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. Material: ...

... CLS number is a new ... match Cornings product number. If ... order under the old Sigma-Aldrich ... service for assistance. ...

Biology Products:

Illumina Standard Data Analysis Report from Asuragen, Inc.CORNING 1700CM2 ROLLER BOTTLE, EASY GRIP CAP, GRADUATED, STERILE from Sigma-Aldrich CORNING ROLLER BOTTLES, 490 CM2, PS CAP, PLUG SEAL, STERILE from Sigma-Aldrich CORNING ROLLER BOTTLE WITH CELLBIND, 1700CM2, STERILE from Sigma-Aldrich